CausalSentinel

Protein Dossier — RET (Proto-oncogene tyrosine-protein kinase receptor Ret)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Hirschsprung’s disease -1.83 0.513 3.69e-04 Wald ratio 1 cis NA
Cancer code self-reported: small intestine or small bowel cancer 0.749 0.259 0.00378 Wald ratio 1 cis NA
Alzheimer’s disease 0.193 0.0723 0.0077 Wald ratio 1 cis NA
Diagnoses - main ICD10: D25 Leiomyoma of uterus 0.204 0.0775 0.00848 Wald ratio 1 cis NA
Diagnoses - main ICD10: K57 Diverticular disease of intestine 0.158 0.0646 0.0144 Wald ratio 1 cis NA
Eye problems or disorders: Diabetes related eye disease 0.246 0.109 0.0242 Wald ratio 1 cis NA
Depressive symptoms -0.0325 0.0145 0.0244 Wald ratio 1 cis NA
Cancer code self-reported: prostate cancer 0.224 0.101 0.0268 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hiatus hernia 0.133 0.0617 0.0306 Wald ratio 1 cis NA
Diagnoses - main ICD10: K43 Ventral hernia 0.266 0.125 0.0342 Wald ratio 1 cis NA
Diagnoses - main ICD10: I48 Atrial fibrillation and flutter -0.276 0.137 0.0433 Wald ratio 1 cis NA
Diagnoses - main ICD10: M16 Coxarthrosis [arthrosis of hip] 0.148 0.0774 0.055 Wald ratio 1 cis NA
…and 56 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3220_40_2 RET Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

34 association rows across 19 traits (28 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating RET levels 8e-469 rs2435366 1 GCST90860059 no MR -> candidate analysis
Proto-oncogene tyrosine-protein kinase receptor Ret levels 2e-145 rs10900296 5 GCST90249073 no MR -> candidate analysis
Hirschsprung disease 2e-101 rs2505994 8 GCST005289 no MR -> candidate analysis
Serum levels of protein RET 5e-89 rs1800858 1 GCST90088279 no MR -> candidate analysis
RET protein levels 1e-59 rs3026734 4 GCST90470458 no MR -> candidate analysis
Blood protein levels 4e-56 rs2505535 1 GCST006585 no MR -> candidate analysis
Body mass index 1e-13 rs2472738 1 GCST90662912 MR: beta=0.0107, p=0.317 (cis)
Cerebellar grey matter morphology (MOSTest) 4e-12 rs10900298 1 GCST90728589 no MR -> candidate analysis
Anomalies of pupillary function (PheCode 379.4) 2e-11 rs192917207 1 GCST90480099 no MR -> candidate analysis
Height 3e-9 rs715106 1 GCST90245848 no MR -> candidate analysis
Gut microbial network clusters (Pink (at 1 year) x Any Breas 1e-8 rs2163189 1 GCST90569458 no MR -> candidate analysis
Weight 2e-8 rs1864401 1 GCST90018729 MR: beta=0.0213, p=0.19 (cis)
…and 7 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1945 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
medullary thyroid gland carcinoma 0.935 established (curated) no MR -> candidate analysis
multiple endocrine neoplasia type 2A 0.944 established (curated) no MR -> candidate analysis
multiple endocrine neoplasia type 2B 0.887 established (curated) no MR -> candidate analysis
Hirschsprung disease 0.844 established (curated) no MR -> candidate analysis
pheochromocytoma 0.927 established (curated) no MR -> candidate analysis
multiple endocrine neoplasia type 2 0.909 established (curated) no MR -> candidate analysis
familial medullary thyroid carcinoma 0.871 established (curated) no MR -> candidate analysis
hepatocellular carcinoma 0.426 established (curated) no MR -> candidate analysis
multiple endocrine neoplasia 0.682 established (curated) no MR -> candidate analysis
colorectal cancer 0.547 established (curated) no MR -> candidate analysis
renal agenesis 0.608 established (curated) no MR -> candidate analysis
renal hypodysplasia/aplasia 1 0.683 established (curated) no MR -> candidate analysis
Ondine syndrome 0.789 established (curated) no MR -> candidate analysis
neoplasm 0.277 established (curated) MR: beta=0.11, p=0.162 (cis)
Inherited cancer-predisposing syndrome 0.943 established (curated) no MR -> candidate analysis

Of the 15 rows above, 14 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 15 known modulators (Proto-oncogene tyrosine-protein kinase receptor Ret)
gnomAD constraint pLI=1, LOEUF=0.236 — LoF-INTOLERANT
GWAS Catalog 45 unique SNPs / 90 rows
ClinVar 4466 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance